tiprankstipranks
Trending News
More News >
NewAmsterdam Pharma Company (NAMS)
NASDAQ:NAMS
US Market

NewAmsterdam Pharma Company (NAMS) Revenue

Compare
238 Followers

NewAmsterdam Pharma Company Revenue

NewAmsterdam Pharma Company had a revenue of 348.00K in the quarter ending Sep 30, 2025, with -98.18%. This bring the company's revenue in the last twelve months to 35.24M, Increased -44.94%. In the fiscal year ending Dec 31, 2024, NewAmsterdam Pharma Company had annual revenue of 45.56M with 223.37% growth.
Revenue (ttm)
35.24M
Revenue Growth
P/S Ratio
85.16
Revenue/Employee
$670,044
Employees
68
Market Cap
$3.88B

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
45.56M31.47M+323.37%
Dec 31, 2023
14.09M-88.60M+13.72%
Dec 31, 2022
102.69M-10,269,400,000.00%
Dec 31, 2021
Dec 31, 2020